Table 2.

Tumor response, n (%)

Tumor response	D-TACE-P-L	C-TACE-P-L	P value
CR	9 (18.0)	4 (7.4)	0.113
PR	24 (48.0)	20 (37.0)
SD	12 (24.0)	19 (35.2)
PD	5 (10.0)	11 (20.4)
ORR (CR + PR)	33 (66.0)	24 (44.4)	0.027
DCR (CR + PR + SD)	45 (90.0)	43 (81.0)	0.143

C-TACE-P-L: Conventional transarterial chemoembolization combined with lenvatinib plus programmed cell death 1 inhibitor; D-TACE-P-L: Drug-eluting beads transarterial chemoembolization combined with lenvatinib plus programmed cell death 1 inhibitor; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease; ORR: Objective response rate; DCR: Disease control rate.